Kinase Biology Tools and Services Market Scope
Kinase biology tools and Services are a vital part of molecular biology and immunology research. Kinase is an enzyme that adds a phosphate group to another molecule. Kinase can also phosphorylate the amino acids serine, tyrosine, and threonine in protein targets. Kinase biology techniques also serve a variety of purposes, including cell signalling and regulating the molecular composition of the cell membrane. These also aid in the discovery of genes linked to a variety of human diseases. There are also protein kinases that aid in the activation of epidermal cells, such as Mitogen-activated protein kinase. The rise in the incidence and prevalence of chronic diseases such as cancer and others are driving the market for kinase biology tools and services. Furthermore, the growth of Kinase biology tools and services is expected to be boosted by an increase in clinical trials for commercialization of kinase biology tools in cancer care. Kinase techniques also aid in the regulation of a number of cell functions, including cell division, apoptosis, and the cell cycle. In cancer, these cell processes are used to regulate a variety of cell activities.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | Thermo Fisher (United States), Merck Group(Germany), Illumina (United States), QIAGEN (Germany), New England Biolabs (United States), Promega (United States), Agilent (United States), Roche Holdings, Inc (Switzerland), Takara Bio (Japan) and LGC Ltd (United Kingdom) |
CAGR | % |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Kinase Biology Tools and Services market throughout the predicted period.
Thermo Fisher (United States), Merck Group(Germany), Illumina (United States), QIAGEN (Germany), New England Biolabs (United States), Promega (United States), Agilent (United States), Roche Holdings, Inc (Switzerland), Takara Bio (Japan) and LGC Ltd (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Bio Basic (Canada), Jena Bioscience (Germany) and Molecular Biology Resources (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Kinase Biology Tools and Services market by Type , by Application (Diagnosis and Research) and Region with country level break-up.
On the basis of geography, the market of Kinase Biology Tools and Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In October 2023, Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary, which provides biological research reagents and related technical contract research services, has entered into a Share Purchase Agreement to acquire SignalChem Biotech Inc., a Vancouver-based Canadian biotech company. Sino Biological will acquire 100% of SCB shares and the total value of the acquisition is estimated to be up to USD 48M USD.
In October 2023, Piramal Pharma Limited's Pharma Solutions (PPS) business, a leading Contract Development and Manufacturing Organization (CDMO), formally announced the launch of a world-class high-throughput screening facility that augments the existing in-vitro biology capabilities at its drug discovery services site in Ahmedabad, India.
Influencing Trend:
Growing use of kinase Inhabitars for Cancer treatment
Market Growth Drivers:
Rising Incidence of Infectious Diseases and Genetic Disorders and Technological Advancements in the Life Science Industry
Challenges:
Challenges Pertaining to Molecular Profiling and Routine Challenges in Molecular Biology
Restraints:
Technical Limitation for the Development of the Product.
Opportunities:
Funding and Investments in the Field of Synthetic Biology and Epigenomics and Expanding Applications of Sequencing Technology in Molecular Biology
Key Target Audience
Biotechnology Companies, Research Institutes, Healthcare Industries, Regulatory Bodies and Others